Product: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
Reason for recall: Failed Impurities/Degradation Specifications
Recall initiated: 20170207
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated